Sai Parenterals acquires 60% stake in Prathyak Laboratories

Sai Parenterals acquired a 60% stake in Prathyak Laboratories for ₹15 crore, gaining an R&D platform with 28 scientists and a pipeline of 150 SKUs across 86 molecules. The deal strengthens its complex injectable and oncology capabilities while supporting manufacturing expansion and regulated-market product launches.